Our preliminary studies have demonstrated that in addition to ovarian cancer [6], HE4 was also highly expressed in endometrial cancer [7], emphasis that how the specificity of HE4 as a serum marker of ovarian cancer needs to be reassessed. Here, WFDC2 is linked to endometrial cancer.